1. Introduction {#sec1}
===============

UTIs represent 13% of all healthcare-associated infections in the United States, resulting in prolonged hospital stays, elevated healthcare expenditures, and increased mortality \[[@B1]\]. It is estimated that the economic burden of healthcare-associated UTIs reaches almost 450 million USD each year, accounting for over 13,000 deaths annually \[[@B2], [@B3]\].

The incidence of postoperative UTIs specific to TJA has been previously cited as high as 3.26% \[[@B4]\]. Postoperative UTIs have been described as the most common minor systemic postoperative complication following TJA, surpassing deep venous thrombosis, pneumonia, and renal insufficiency \[[@B5]\]. UTIs in the postoperative setting have been linked to significant adverse events such as periprosthetic infection, implant failure, and subsequent revision procedures, resulting in prolonged and costly hospital stays \[[@B6]--[@B10]\].

Indwelling bladder catheterization is a well-known risk factor for developing a UTI \[[@B11]\]. To date, there is no widely recognized guideline regarding catheterization in the perioperative setting of TJA, with surgeon preference largely determining bladder management \[[@B12], [@B13]\]. Routine catheterization has been employed at many surgical centers in order to avoid postoperative urinary retention, something for which patients undergoing TJA are known to be at increased risk, and which itself is associated with UTIs \[[@B14], [@B15]\].

UTIs are of special interest given the considerable frequency of patient-reported lower urinary tract symptoms in the perioperative setting being as high as 94% \[[@B16]\]. The identification of independently associated risk factors for postoperative UTIs may help orthopaedic surgeons in managing such patients.

A CMS reimbursement policy has recently been proposed in order to increase the focus on quality of care rather than volume \[[@B17]\]. In this proposal, hospitals are not reimbursed for treatment of avoidable complications, such as UTIs, postoperatively following TJA. Avoiding such postoperative adverse events is beneficial not only in terms of patient care but also for surgeon quality metrics and reimbursement. The purpose of this study is to identify the risk factors and to quantify the risk of developing a postoperative UTI following TJA.

2. Materials and Methods {#sec2}
========================

This study uses the ACS-NSQIP Database for the years 2006--2013. The ACS-NSQIP Database is a program that collects data preoperatively and up to 30 days postoperatively. This program includes data from over 600 hospitals in 49 of 50 states and in 13 other countries \[[@B18]\]. Each clinical site employs clinical reviewers who collect data through chart review and, if necessary, direct physician or patient contact.

Patients were identified using the CPT codes 27447 and 27130 for total knee and total hip arthroplasty, respectively. Patients were then further selected via ICD-9 code prefix of 715.x to include only those patients with primary diagnosis of osteoarthritis. Patients with concurrent or other procedures performed during the same admission, as well as those with a diagnosis of UTI prior to admission, were excluded. The presence of a UTI was a reported variable for patients in the ACS-NSQIP Database, ascertained via the standardized process as described above.

A univariate analysis (Pearson Chi-Square or Fisher exact test) of all available demographic variables, preoperative laboratory values, comorbidities, and operative characteristics was employed to identify variables significantly associated with a postoperative UTI. A *p* value of 0.05 or less was considered significant. To control for confounders, a multivariate analysis was then utilized. Covariates included in binary logistic regression analysis were those that demonstrated both a significant association with postoperative UTI with a *p* value ≤ 0.2 and had at least 10 occurrences present \[[@B19]\]. Statistical analysis was performed with SPSS version 22 (Chicago, IL).

3. Results {#sec3}
==========

1239 (1.1%) of 115,630 total patients who met all inclusion criteria experienced a postoperative UTI. Overall, females experienced postoperative UTIs more frequently than males (1.3% versus 0.8%, *p* \< 0.001). The mean age of patients who experienced a postoperative UTI was greater than those who did not (70.89 ± 9.8 versus 66.54 ± 10.3%, *p* \< 0.001). Neither race nor BMI (*p* = 0.165 and 0.443, resp.) was risk factors for developing a postoperative UTI ([Table 1](#tab1){ref-type="table"}). Smoking, severe chronic obstructive pulmonary disease, hypertension, and previous percutaneous coronary intervention (PCI)/cardiac surgery, as well as previous TIA or stroke were significantly associated with postoperative UTIs (all *p* \< 0.05); however, congestive heart failure and disseminated cancer were not.

Patients with an ASA classes 3--5 were more likely to experience a postoperative UTI as compared to those with ASA classes 1-2 (1.4% versus 0.8%, *p* \< 0.001). Additionally, patients undergoing general anesthesia were more likely to develop a postoperative UTI compared to those undergoing spinal or other (including regional and local) anesthesia (1.1% versus 1.0% versus 0.8%, respectively, *p* = 0.022) ([Table 2](#tab2){ref-type="table"}). Evaluation of preoperative laboratory values revealed elevated creatinine and were associated with postoperative UTIs (*p* \< 0.05); however, platelets and hematocrit were not ([Table 2](#tab2){ref-type="table"}).

A multivariate binary logistic model was able to identify which variables were independently associated with postoperative UTIs, adjusting for confounding variables ([Table 3](#tab3){ref-type="table"}). Increasing age was identified as the strongest variable in developing a postoperative UTI: 60--69 (OR, 1.5; 95% CI, 1.0--2.1), 70--79 (OR, 2.0; 95% CI, 1.4--2.9), and ≥80 (OR, 2.3; 95% CI, 1.5--3.6) ([Table 3](#tab3){ref-type="table"}). Female sex was also strongly associated with increased odds of postoperative UTI in our multivariate analysis (OR, 2.1; 95% CI, 1.6--2.7), as were steroid use (OR, 2.0; 95% CI, 1.2--3.2), operative time greater than 130 minutes (overall mean + 1 SD) (OR, 1.8; 95% CI, 1.3--2.4), and preoperative creatinine greater than 1.35 (overall mean + 1 SD) (OR, 1.8; 95% CI, 1.3--2.6).

4. Discussion {#sec4}
=============

With recent nationwide quality initiatives to minimize healthcare-associated infections, the ability to identify and manage patients at the greatest risk of postoperative UTIs has become an increasingly important topic in the orthopaedic arena. While many of these quality improvement initiatives have helped to limit bladder catheterization and thus prevent UTIs, it is clear that UTI in the postoperative TJA setting is not uncommon.

Considerable research has been conducted regarding nosocomial UTIs in general; however, research pertaining to UTIs strictly in TJA patients is sparse \[[@B11], [@B14], [@B15], [@B20]\]. Moreover, previously established risk factors for any nosocomial UTI, including female sex, diabetes mellitus, and elevated creatinine, were consistent with the findings in our study \[[@B11]\]. Whether the additional risk factors identified in our study are unique to the TJA population or broadly applicable to other patient groups, cannot be definitively concluded at this time.

With regards to postsurgical patients in other surgical specialties, research indicates that the appreciable incidence of postoperative UTIs is not exclusive to orthopaedic surgery \[[@B20]\]. One study investigating the incidence of postoperative UTIs following major surgeries in various specialties revealed that the rates are indeed similar across multiple surgical services: 30-day postoperative UTI rate for coronary artery bypass, vascular, colorectal, and TJA surgeries were 3.3, 3.4, 4.0, and 3.4%, respectively \[[@B20]\].

It is recognized that our study is limited by the absence of patient bladder catheterization data (including presence of indwelling catheter and duration) within the ACS-NSQIP Database, which may have impacted results. For example, it can be hypothesized that patient populations with characteristics we found to be significantly associated with postoperative UTIs, such as advanced age or ASA status 3--5, were more likely to be catheterized and thus at increased risk for UTI. Further studies with strict data collection would be able to provide more clarification.

Another potential limitation of this study includes its retrospective nature, as well as the intrinsic variability in data collection from multiple sites. However, the ACS-NSQIP program has implemented extensive training and auditing procedures for each participating hospital to ensure the collection of reliable data and a high level of verified interrater reliability \[[@B21]\]. Various analyses have demonstrated that, across most hospitals and models, the reliability of the ACS-NSQIP data is reasonable for assessing surgical quality \[[@B22]\].

Our study has identified multiple characteristics independently associated with postoperative UTIs following TJA, which may be useful to clinicians in identifying at-risk patients. While this information alone may have the potential to improve the quality of patient care, at this time, the clinical utility of these risk factors is unproven. Further research such as a prospective study stratifying patients into risk groups to guide postoperative management or perioperative catheterization may be employed to establish practical utility.
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###### 

Preoperative characteristics.

  Characteristic                         No UTI                UTI                 *p* value
  -------------------------------------- ------------- ------- ------------ ------ -----------
  Number of patients                     114391        98.9%   1239         1.1%    
  Age (years) (mean, SD)^*∗*^            66.54, 10.3           70.89, 9.8          \<0.001
   \<59                                  28165         99.4%   160          0.6%    
   60--69                                40511         99.1%   353          0.9%    
   70--79                                32296         98.6%   453          1.4%    
   80+                                   12717         98.0%   258          2.0%    
  BMI (mean, SD)                         31.8, 7.1             32.1, 7.4           0.443
   Underweight                           681           98.6%   10           1.4%    
   Normal                                15569         98.9%   166          1.1%    
   Overweight                            34871         99.0%   349          1.0%    
   Obese (Class 1)                       30823         98.9%   348          1.1%    
   Obese (Class 2)                       18441         98.9%   201          1.1%    
   Obese (Class 3)                       13787         98.8%   162          1.2%    
  Sex^*∗*^                                                                         \<0.001
   Male                                  45263         99.2%   343          0.8%    
   Female                                68968         98.7%   895          1.3%    
  Race                                                                             0.165
   White                                 91973         99.0%   967          1.0%    
   Black                                 7190          98.7%   92           1.3%    
   Asian                                 2024          99.2%   16           0.8%    
   Other/unknown                         4533          98.8%   53           1.2%    
  Current smoker^*∗*^                    11107         99.3%   82           0.7%   \<0.001
  Steroid use^*∗*^                       3229          97.9%   68           2.1%   \<0.001
  Comorbidities                                                                     
   Diabetes mellitus^*∗*^                                                          \<0.001
    Non-insulin dependent                13465         98.7%   171          1.3%    
    Insulin-dependent                    4122          98.2%   74           1.8%    
   Disseminated cancer                   143           97.3%   4            2.7%   0.074
   Dyspnea^*∗*^                          7528          98.5%   115          1.5%   \<0.001
   COPD^*∗*^                             4163          98.4%   68           1.6%   0.001
   Hypertension^*∗*^                     72760         98.8%   916          1.2%   \<0.001
   Open wound/wound infection^*∗*^                                                 0.002
   Congestive heart failure \< 30 days   267           98.2%   5            1.8%   0.223
   Bleeding disorders^*∗*^               2952          98.2%   53           1.8%   \<0.001
   Previous PCI/cardiac surgery^*∗*^     3311          98.1%   64           1.9%   0.006
   Previous TIA/stroke^*∗*^              1793          98.1%   35           1.9%   0.04
  ASA class^*∗*^                                                                   \<0.001
   1, 2                                  63731         99.2%   513          0.8%    
   3, 4, 5                               50541         98.6%   723          1.4%    
  Functional status^*∗*^                                                           \<0.001
   Dependent                             2616          98.2%   49           1.8%    
   Independent                           111250        98.9%   1185         1.1%    

*∗* denotes significance.

###### 

Operative and lab characteristics.

  Characteristic                           No UTI                UTI                  *p* value
  ---------------------------------------- ------------- ------- ------------- ------ -----------
  Total operative time (mins) (mean, SD)   92.63, 37.2           95.21, 45.5          0.128
   \<130.0                                 100143        98.9%   1067          1.1%    
   \>130.0                                 14234         98.8%   172           1.2%    
  Anesthesia type^*∗*^                                                                0.022
   General                                 61043         98.9%   710           1.1%    
   Spinal                                  43710         99.0%   452           1.0%    
   Other (including regional and local)    5776          99.2%   48            0.8%    
  Creatinine \> mean + 1 SD (1.35)^*∗*^    6180          98.1%   121           1.9%   \<0.001
  Platelets \< 50                          195           99.0%   2             1.0%   0.934
  Hematocrit values \< 21                  184           98.9%   2             1.1%   0.999
  INR \> 2^*∗*^                            751           98.2%   14            1.8%   0.047

*∗* denotes significance.

###### 

Independent risk factors for postop UTI as defined by multivariate logistic regression.

  Variable                                         OR (95% CI)
  ------------------------------------------------ ----------------
  Sex (female)^*∗*^                                2.1 (1.6--2.7)
  Diabetes                                          
   Non-insulin dependent                           1.2 (0.9--1.7)
   Insulin dependent                               1.6 (0.9--2.5)
  Smoker                                           1.0 (0.6--1.5)
  Dyspnea                                          0.9 (0.6--1.4)
  Functional status (dependent)                    0.9 (0.5--1.6)
  COPD                                             1.2 (0.7--2.0)
  Hypertension                                     0.9 (0.7--1.2)
  Steroid use^*∗*^                                 2.0 (1.2--3.2)
  Bleeding disorder                                1.3 (0.8--2.2)
  Age                                               
   60--69^*∗*^                                     1.5 (1.0--2.1)
   70--79^*∗*^                                     2.0 (1.4--2.9)
   ≥80^*∗*^                                        2.3 (1.5--3.6)
  History of PCI/cardiac surgery                   1.3 (0.9--1.8)
  History of TIA/stroke                            1.1 (0.7--1.7)
  ASA classes 3--5^*∗*^                            1.5 (1.2--1.9)
  Preop Cr \> 1.35^*∗*^                            1.8 (1.3--2.6)
  Preop INR \> 2                                   0.6 (0.2--2.0)
  Operation time \> mean + 1 SD (130 mins.)^*∗*^   1.8 (1.3--2.4)
  Anesthesia type                                   
   Spinal                                          0.9 (0.7--1.2)
   Other                                           0.7 (0.4--1.3)

*∗* denotes significance.
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